BLAINJECTIONINJECTABLE2 Generics Approved
Approved
Jun 1991
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
20
Data completeness
4/8 — Partial
NOVOLIN R (human insulin) by Novo Nordisk. Approved for insulin [epc]. First approved in 1991.
Drug data last refreshed 17h ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
NOVOLIN R is a recombinant human insulin approved in 1991 for the treatment of diabetes mellitus. It is a rapid-acting insulin administered by injection that helps regulate blood glucose levels in patients who cannot produce sufficient endogenous insulin. The drug works by mimicking the body's natural insulin to facilitate glucose uptake and utilization.
$37MPart D
LOE ApproachingThis mature product faces patent expiration with declining market dominance, suggesting a smaller, maintenance-focused team structure with emphasis on cost optimization and market defense.
Mechanism of Action
Pharmacologic Class:
Insulin
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (20)
Defining the Human Insulin Resistance Molecular Network; SIGNATURE
Started Dec 2025
80 enrolled
Metabolic HealthInsulin Sensitivity/Resistance
A Trial to Investigate Post Prandial Blood Glucose Control With Fast-acting Human Insulin HinsBet® Compared to Insulin Lispro (Humalog®) and Regular Human Insulin (Huminsulin® Normal) After Ingestion of a Standardized Meal in Subjects With T1DM
Started Apr 2016
36 enrolled
Type 1 Diabetes Mellitus
A Double-blinded, Randomised, Three-period Crossover Euglycaemic Clamp Trial Investigating the Pharmacokinetics, Glucodynamics and Safety of BioChaperone Human Insulin, Human Insulin (Huminsulin® Normal) and Insulin Lispro (Humalog®) in Subjects With Type 1 Diabetes
Started Aug 2014
38 enrolled
Diabetes Mellitus Type 1
A Study of LY2605541 (Insulin Peglispro) and Human Insulin Concentrations in Fat Tissue
Started Apr 2014
24 enrolled
Diabetes Mellitus, Type 1
Investigating Efficacy and Safety of Biphasic Insulin Aspart 50 Twice Daily Versus Biphasic Human Insulin 50 Twice Daily Both in Combination With Metformin in Chinese Subjects With Type 2 Diabetes Mellitus
Started Jun 2013
161 enrolled
DiabetesDiabetes Mellitus, Type 2
Worked on NOVOLIN R at Novo Nordisk? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.